Загрузка...
Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases
Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempti...
Сохранить в:
| Опубликовано в: : | Breast Care (Basel) |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger GmbH
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7204783/ https://ncbi.nlm.nih.gov/pubmed/32398983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501473 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|